Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Colorectal Cancer: Personalized Therapy.
Leichsenring J, Koppelle A, Reinacher-Schick A. Leichsenring J, et al. Gastrointest Tumors. 2014 May;1(4):209-20. doi: 10.1159/000380790. Epub 2015 Apr 15. Gastrointest Tumors. 2014. PMID: 26676107 Free PMC article. Review.
Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients.
Overheu O, Lendowski S, Quast DR, Kühn D, Vidal Blanco E, Kraeft AL, Steinmann E, Kourti E, Lugnier C, Steinmann J, Reinacher-Schick A, Pfaender S. Overheu O, et al. J Cancer Res Clin Oncol. 2023 Sep;149(12):10633-10644. doi: 10.1007/s00432-023-04961-2. Epub 2023 Jun 10. J Cancer Res Clin Oncol. 2023. PMID: 37300723 Free PMC article.
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Weiss L, Heinemann V, Fischer LE, Gieseler F, Hoehler T, Mayerle J, Quietzsch D, Reinacher-Schick A, Schenk M, Seipelt G, Siveke JT, Stahl M, Vehling-Kaiser U, Waldschmidt DT, Dorman K, Zhang D, Westphalen CB, von Bergwelt-Baildon M, Boeck S, Haas M. Weiss L, et al. Among authors: reinacher schick a. Clin Transl Oncol. 2024 May;26(5):1268-1272. doi: 10.1007/s12094-023-03323-1. Epub 2023 Oct 4. Clin Transl Oncol. 2024. PMID: 37794220 Free PMC article.
68Ga-Labeled Fibroblast Activation Protein Inhibitor (68Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial.
Kessler L, Hirmas N, Pabst KM, Hamacher R, Ferdinandus J, Schaarschmidt BM, Milosevic A, Nader M, Umutlu L, Uhl W, Reinacher-Schick A, Lugnier C, Witte D, Niedergethmann M, Herrmann K, Fendler WP, Siveke JT. Kessler L, et al. Among authors: reinacher schick a. J Nucl Med. 2023 Dec 1;64(12):1910-1917. doi: 10.2967/jnumed.122.264827. J Nucl Med. 2023. PMID: 37973185
Correction: Effect of transcutaneous auricular vagal nerve stimulation on the fatigue syndrome in patients with gastrointestinal cancers - FATIVA: a randomized, placebo‑controlled pilot study protocol.
Gierthmuehlen M, Höffken N, Timmesfeld N, Schmieder K, Reinacher-Schick A. Gierthmuehlen M, et al. Pilot Feasibility Stud. 2023 Jun 3;9(1):94. doi: 10.1186/s40814-023-01331-0. Pilot Feasibility Stud. 2023. PMID: 37270522 Free PMC article. No abstract available.
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV.
Simsek A, Bessen C, Meister TL, Urlaub D, Skaletz-Rorowski A, Brockmeyer NH, Overheu O, Reinacher-Schick A, Faissner S, Watzl C, Pfaender S, Schmitz I, Potthoff A, Plaza-Sirvent C. Simsek A, et al. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e825-e827. doi: 10.1111/jdv.19036. Epub 2023 Mar 24. J Eur Acad Dermatol Venereol. 2023. PMID: 36912717 No abstract available.
What do German Molecular Tumor Boards recommend in patients with PIK3CA mutated tumors? - Launch and first results from the German TEAM-D Transsectoral Molecular Tumor Board exchange platform Deutschland (TEAM-D).
Pretzell I, Desuki A, Bleckmann A, Loges S, Reinacher-Schick A, Westphalen CB, Lange S; TEAM-D Participants. Pretzell I, et al. Among authors: reinacher schick a. Oncol Res Treat. 2024 May 7. doi: 10.1159/000539217. Online ahead of print. Oncol Res Treat. 2024. PMID: 38714183
166 results